A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of C-Met and Vascular Endothelial Growth Factor Receptor 2

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0574
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Recombinant Mutant Vascular Endothelial Growth Factor-C That Has Lost Vascular Endothelial Growth Factor Receptor-2 Binding, Activation, and Vascular Permeability Activities

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Preclinical Characterization of Anlotinib, a Highly Potent and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor

Cancer Science
Cancer ResearchMedicineOncology
2018English

Phase I Study of SU5416, a Small Molecule Inhibitor of the Vascular Endothelial Growth Factor Receptor (VEGFR) in Refractory Pediatric Central Nervous System Tumors

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

Deflection of Vascular Endothelial Growth Factor Action by SS18-SSX and Composite Vascular Endothelial Growth Factor- And Chemokine (C-X-C Motif) Receptor 4-Targeted Therapy in Synovial Sarcoma

Cancer Science
Cancer ResearchMedicineOncology
2014English

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients With Refractory Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Brunner’s Gland Lesions in Rats Induced by a Vascular Endothelial Growth Factor Receptor Inhibitor

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2014English

A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

Clinical Genitourinary Cancer
OncologyUrology
2013English

Nuclear Receptor COUP-TFII Controls Pancreatic Islet Tumor Angiogenesis by Regulating Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 Signaling

Cancer Research
Cancer ResearchOncology
2010English

Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy